Article

New Research and Developments in the Treatment of COPD

Victor Kim, MD, Assistant Professor of Medicine, Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses chronic obstructive pulmonary disease (COPD) risk factors, and current research and developments in the treatments of COPD.

Related Videos
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
A panel of 3 experts on COPD
A panel of 3 experts on COPD
A Promising Pipeline for COPD
Projecting Dupilumab's Fit in COPD
What the Ensifentrine FDA Approval Means for COPD
3 KOLs are featured in this program.
3 KOLs are featured in this program.
Video 10 - "Future Treatment Landscape for COPD"
Related Content
Updates to Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report Released
November 18th 2024

Updates to Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report Released

Tim Smith
Checking in on the Lung Health Cohort Trial
October 29th 2024

Checking in on the Lung Health Cohort Research Study

Kevin Kunzmann
Burn Pit Exposure Linked to Migraine, Headache Disorders in US Veterans
October 18th 2024

Burn Pit Exposure Linked to Migraine, Headache Disorders in US Veterans

Chelsie Derman
Lung Imaging 2.0: How AI is Shaping the Future with Rachel Eddy, PhD
September 30th 2024

Lung Imaging 2.0: How AI is Shaping the Future with Rachel Eddy, PhD

Kevin Kunzmann
Antonio Anzueto, MD | Credit: UT Health San Antonio
October 14th 2024

The Potential Role of Dupilumab in COPD Management, with Antonio Anzueto, MD

Patrick Campbell
Stephanie Christenson, MD | Credit: American Lung Association
October 14th 2024

Stephanie Christenson, MD: An "Exciting" New Era in COPD Management

Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.